170 related articles for article (PubMed ID: 7525466)
1. Grafting of a hepatitis B S-preS(2) T-cell epitope on lysozyme enhances the immunogenicity of lysozyme in responder mice primed with the T-cell epitope.
Scheerlinck JP; Michel A; De Baetselier P
Immunol Lett; 1994 Jun; 41(1):25-32. PubMed ID: 7525466
[TBL] [Abstract][Full Text] [Related]
2. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
[TBL] [Abstract][Full Text] [Related]
3. Modification of the inhibitory amino acid for epitope peptide binding onto major histocompatibility complex class II molecules enhances immunogenicity of the antigen.
Chang SH; Kim J; Lee KY; Kim HJ; Chung YJ; Park CU; Kim BS; Jang YS
Scand J Immunol; 2004 Feb; 59(2):123-32. PubMed ID: 14871288
[TBL] [Abstract][Full Text] [Related]
4. T cell epitope recognition involved in the low-responsiveness to a region of hen egg lysozyme (46-61) in C57BL/6 mice.
Jang YS; Mikszta JA; Kim BS
Mol Immunol; 1994 Aug; 31(11):803-12. PubMed ID: 7519304
[TBL] [Abstract][Full Text] [Related]
5. Antigen presentation by non-immune B-cell hybridoma clones: presentation of synthetic antigenic sites reveals clones that exhibit no specificity and clones that present only one epitope.
Cohly HH; Morrison DR; Atassi MZ
Immunol Invest; 1989 Oct; 18(8):987-92. PubMed ID: 2479600
[TBL] [Abstract][Full Text] [Related]
6. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
7. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.
Scheerlinck JP; Burssens G; Brys L; Michel A; Hauser P; De Baetselier P
Immunology; 1991 May; 73(1):88-94. PubMed ID: 2045130
[TBL] [Abstract][Full Text] [Related]
8. Constraints in antigen processing result in unresponsiveness to a T cell epitope of hen egg lysozyme in C57BL/6 mice.
Kim BS; Jang YS
Eur J Immunol; 1992 Mar; 22(3):775-82. PubMed ID: 1372259
[TBL] [Abstract][Full Text] [Related]
9. Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides.
Steward MW; Partidos CD; D'Mello F; Howard CR
Vaccine; 1993 Nov; 11(14):1405-14. PubMed ID: 7508664
[TBL] [Abstract][Full Text] [Related]
10. Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide.
Rajadhyaksha M; Thanavala Y
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1575-9. PubMed ID: 7878021
[TBL] [Abstract][Full Text] [Related]
11. Immunodominance of a recombinant T-cell epitope depends on its molecular environment.
Leclerc C; Martineau P; Charbit A; Lo-Man R; Dériaud E; Hofnung M
Mol Immunol; 1993 Dec; 30(17):1561-72. PubMed ID: 8247026
[TBL] [Abstract][Full Text] [Related]
12. Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains.
Pride MW; Thakur A; Thanavala Y
J Exp Med; 1993 Jan; 177(1):127-34. PubMed ID: 7678109
[TBL] [Abstract][Full Text] [Related]
13. Processing and reactivity of T cell epitopes containing two cysteine residues from hen egg-white lysozyme (HEL74-90).
Kang HK; Mikszta JA; Deng H; Sercarz EE; Jensen PE; Kim BS
J Immunol; 2000 Feb; 164(4):1775-82. PubMed ID: 10657624
[TBL] [Abstract][Full Text] [Related]
14. Conversion of low antibody responders into high responders by up-regulating the T cell response to a selective epitope.
Mikszta JA; Kim BS
J Immunol; 1996 Oct; 157(7):2883-90. PubMed ID: 8816393
[TBL] [Abstract][Full Text] [Related]
15. Homogeneous processing and presentation of a recombined T cell epitope in inbred mice of different non-MHC genetic background.
Lo-Man R; Martineau P; Hofnung M; Leclerc C
Cell Immunol; 1996 Sep; 172(2):180-91. PubMed ID: 8964079
[TBL] [Abstract][Full Text] [Related]
16. In a vaccine model, selected substitution of a highly stimulatory T cell epitope of hen's egg lysozyme into a Salmonella flagellin does not result in a homologous, specific, cellular immune response and may alter the way in which the total antigen is processed.
Vanegas RA; Street NE; Joys TM
Vaccine; 1997 Feb; 15(3):321-4. PubMed ID: 9139493
[TBL] [Abstract][Full Text] [Related]
17. mAb against hen egg-white lysozyme regulate its presentation to CD4(+) T cells.
Guermonprez P; Lo-Man R; Sedlik C; Rojas MJ; Poljak RJ; Leclerc C
Int Immunol; 1999 Nov; 11(11):1863-72. PubMed ID: 10545490
[TBL] [Abstract][Full Text] [Related]
18. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg.
Milich DR; McLachlan A; Chisari FV; Kent SB; Thorton GB
J Immunol; 1986 Jul; 137(1):315-22. PubMed ID: 2423607
[TBL] [Abstract][Full Text] [Related]
19. Reversal of T cell unresponsiveness by augmentation of antigen presenting cell function.
Doherty TM; Love SG; Harding DR; Watson JD
Int Immunol; 1994 May; 6(5):761-8. PubMed ID: 7521669
[TBL] [Abstract][Full Text] [Related]
20. Analysis of T cell reactivities to phosphorylcholine-conjugated hen egg lysozyme in C57BL/6 mice: hapten-conjugate specificity reflects an altered expression of a major carrier epitope.
Jang YS; Lim KH; Kim BS
Eur J Immunol; 1991 May; 21(5):1303-10. PubMed ID: 1709872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
